home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Medical Science Liaisons Deal in the Currency of Information: How Are You Cashing In?

 
  May 15, 2024  
     
 
Xtalks, Online
2024-06-04


This webinar will unravel the challenges in quantifying medical science liaisons’ value, explore how they are enhancing impact through strategic engagement, unpack new ways of measuring value beyond output and illustrate how companies can further empower medical science liaisons with data-driven artificial intelligence (AI)/tech-enabled solutions.

While the medical science liaison role is expanding across all stages of pharmaceutical development and to encompass a growing number of audiences, the industry is struggling to measure the impact of medical science liaison activities. However, the race is on to develop the right key performance indicators, training, measurement tools and processes for gauging the impact of medical science liaison teams and ultimately improving outcomes.

Medical science liaisons within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering. Only they can share certain types of information with a growing number of medical stakeholders and provide medical insights to guide strategic development and brand decisions.

In this webinar, the attendees will learn about how medical science liaisons can strategically engage with a variety of stakeholders to gather critical insights that shape medical strategies and influence development decisions; discover how customized solutions, such as AI-driven sentiment analysis and insights reporting, can enhance medical science liaisons’ capabilities; and explore innovative methods for assessing the impact of medical science liaisons’ activities.

Do not miss this opportunity to gain actionable strategies for maximizing the value of medical science liaisons and driving better outcomes in pharmaceutical development.

Keywords: Real-World Data, Patient Outcomes, Real-World Evidence, Medical Affairs, Marketing, Medical Science Liaison, AI, RWE, Commercialization/HEOR/Market Access, Other Research, RWD
 
 
Organized by: Xtalks
Invited Speakers: Angela Wlodar, MS, Senior Vice President, Medical Affairs Business Development, Syneos Health
Mike DeGeorge, PharmD, BCMAS, Vice President, Medical Affairs, Deployment Solutions, Syneos Health
Mayank Pandita, Director, Strategic Business Analytics, Deployment Solutions, Syneos Health
Celeste Mosby, Senior Vice President and General Manager, Learning Solutions, Syneos Health
 
Deadline for Abstracts: 2024-06-04
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.